OTL-103, OTL-103
WAS-TLT003-01
Phase 3 small_molecule active
Quick answer
OTL-103, OTL-103 for Wiskott-Aldrich syndrome (WAS) is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Wiskott-Aldrich syndrome (WAS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active